GMiA
GMiA
 GMiA

Announcing the release of GMiA's Code of Practice, available here

Announcing stakeholder consultation of GMiA’s draft second edition Code of Practice here

The Generic Medicines industry Association (GMiA)
provides a unified voice representing the interests
of the generic prescription medicines industry in Australia
The GMiA was established to develop good relationships with all constituencies involved in ensuring the continued delivery of pharmaceutical care to the Australian community and to contribute to the long term sustainability of the Pharmaceutical Benefits Scheme (PBS) through support of the principles of the National Medicines Policy.

GMiA is your support in matters relating
to the generic pharmaceuticals industry
GMiA members:
  • Supply > 90% of prescriptions from generic sponsors (PBPA annual report 2008/09)
  • Sold 50 million or 33% of prescriptions on PBS (PBPA annual report 2008/09)
  • Sold 100 million packs in Australia; a large proportion of the generic sector is below the PBS co-payment (GMiA survey 2009)
  • Employ 5,000 Australians; almost half in manufacturing or R&D roles representing functions that generate strong economic multiplier benefits (GMiA survey 2009)
  • Exports $470 million in value of pharmaceuticals (GMiA survey 2009) which represents 12% of current pharmaceutical export market or 17% of forecast pharmaceutical market in 2010
As a matter of basic principle the GMiA:
  • Supports the PBS and its long term affordability
  • Supports the principles of the Quality Use of Medicines
  • Supports the development of policies that ensure access to pharmaceutical care for all Australians
  • Encourages professional awareness and general knowledge of the safety, quality and efficacy of generic medicines
  • Supports balanced and generic-friendly intellectual property rights in the pharmaceutical sector that enable timely access to generic medicines
Developed by The Pagesmith © GMiA 2010